Immunohistochemistry (IHC) in samples from 74 patients revealed that GFAP expression (a marker of glioma cell differentiation) decreased, while the levels of FMRP and Ki67 increased with grade (Figure 1C). The gene discussed is MKI67; the disease is glioma.